The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Phenyl)-4-(3'-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepine ID: ALA456156
PubChem CID: 44587921
Max Phase: Preclinical
Molecular Formula: C21H17NOS
Molecular Weight: 331.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Oc1cccc(C2=Nc3ccccc3SC(c3ccccc3)C2)c1
Standard InChI: InChI=1S/C21H17NOS/c23-17-10-6-9-16(13-17)19-14-21(15-7-2-1-3-8-15)24-20-12-5-4-11-18(20)22-19/h1-13,21,23H,14H2
Standard InChI Key: DZJYISGBNCCXKA-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
-1.7559 1.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1461 0.6955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4966 0.7559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9345 1.4529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7095 -0.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8848 0.0227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3396 -0.6046 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.2004 -0.6800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4864 -1.4193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9814 -1.4812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2180 -1.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6933 -1.8980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4096 -1.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1204 -1.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1161 -2.7286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3951 -3.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6872 -2.7186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8361 -1.4954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2329 -1.8151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2463 -2.6401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9665 -3.0391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6735 -2.6143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6561 -1.7862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9354 -1.3909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 2 0
12 13 2 0
6 3 1 0
13 14 1 0
6 7 1 0
14 15 2 0
1 2 2 0
15 16 1 0
5 8 1 0
16 17 2 0
17 12 1 0
10 12 1 0
3 4 2 0
14 18 1 0
7 9 1 0
4 1 1 0
19 20 2 0
8 10 2 0
20 21 1 0
2 5 1 0
21 22 2 0
9 11 1 0
22 23 1 0
10 11 1 0
23 24 2 0
24 19 1 0
9 19 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 331.44Molecular Weight (Monoisotopic): 331.1031AlogP: 5.75#Rotatable Bonds: 2Polar Surface Area: 32.59Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.18CX Basic pKa: 1.11CX LogP: 5.53CX LogD: 5.47Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.65Np Likeness Score: -0.47
References 1. Ansari FL, Iftikhar F, Ihsan-Ul-Haq, Mirza B, Baseer M, Rashid U.. (2008) Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines., 16 (16): [PMID:18650096 ] [10.1016/j.bmc.2008.07.009 ] 2. Ansari FL, Kalsoom S, Zaheer-ul-Haq, Ali Z, Jabeen F. (2012) In silico studies on 2,3-dihydro-1,5-benzothiazepines as cholinesterase inhibitors, 21 (9): [10.1007/s00044-011-9754-6 ] 3. Jabeen F, Oliferenko PV, Oliferenko AA, Pillai GG, Ansari FL, Hall CD, Katritzky AR.. (2014) Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis., 80 [PMID:24780600 ] [10.1016/j.ejmech.2014.04.018 ]